Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Change in Accured Expenses: 2019-2025

Historic Change in Accured Expenses for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to -$81,000.

  • Benitec Biopharma's Change in Accured Expenses rose 111.11% to $1,000 in Q2 2025 from the same period last year, while for Jun 2025 it was -$81,000, marking a year-over-year decrease of 307.69%. This contributed to the annual value of -$81,000 for FY2025, which is 307.69% down from last year.
  • Latest data reveals that Benitec Biopharma reported Change in Accured Expenses of -$81,000 as of FY2025, which was down 307.69% from $39,000 recorded in FY2024.
  • In the past 5 years, Benitec Biopharma's Change in Accured Expenses ranged from a high of $121,000 in FY2021 and a low of -$81,000 during FY2025.
  • In the last 3 years, Benitec Biopharma's Change in Accured Expenses had a median value of $39,000 in 2024 and averaged $10,333.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first skyrocketed by 112.28% in 2021, then crashed by 307.69% in 2025.
  • Benitec Biopharma's Change in Accured Expenses (Yearly) stood at $121,000 in 2021, then crashed by 33.88% to $80,000 in 2022, then fell by 8.75% to $73,000 in 2023, then slumped by 46.58% to $39,000 in 2024, then plummeted by 307.69% to -$81,000 in 2025.